Company News

LOADING
  • Read More BiOptic Inc., Giant Bio Technology Inc. and NTOU have jointly publised a journal article on MDPI

    BiOptic Inc., Giant Bio Technology Inc. and NTOU have jointly publised a journal article on MDPI

    2022-02-17

    According to the 2018 market survey report, the global farmed shrimp market is about 28 billion U.S. dollars. Due to the globalization and high-density of aquaculture industry, the spread of diseases has accelerated. Among them, shrimp infectious diseases will outbreak every few years, including white Spot disease (WSD), acute hepatopancreatic necrosis disease (AHPND), and hepatopancreatic microsporidia (HPM), which reduce the industry profit with an estimated $7.8 billion annually.

  • Read More BiOptic Inc. was listed on Taiwan’s Emerging Stock Board from Q4, 2021

    BiOptic Inc. was listed on Taiwan’s Emerging Stock Board from Q4, 2021

    2021-12-28

    BiOptic Inc.’s self-developed COVID-19 test kit has been formally submitted to the European Union a few days ago to apply for in vitro diagnostic medical device (CE-IVD) certification.

  • Read More BiOptic has won the 20th Pharmaceutical Technology Research & Development Award- Golden Award

    BiOptic has won the 20th Pharmaceutical Technology Research & Development Award- Golden Award

    2021-11-30

    BiOptic has won the 20th Pharmaceutical Technology Research & Development Award- Golden Award

  • Read More Congratulations! BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award!

    Congratulations! BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award!

    2021-11-22

    BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award for its "Qsep1-Lite Bio-Fragment Analyzer" from the Ministry of Economic Affairs, R.O.C.

  • Read More BiOptic has certificated by UL in conformance with FDA 21 CFR Part 11

    BiOptic has certificated by UL in conformance with FDA 21 CFR Part 11

    2021-02-19

    The software system of Qsep series bio-fragment analyzer, Q-Analyzer, which is developed by BiOptic, has certificated by UL in conformance with FDA 21 CFR Part 11 in Jan 2021. The FDA guidelines for Data Integrity include the requirement for compliance for the storage of electronic records. Nearly all the medical-related industries follow this standard, which gains on the safety of information security and data management of the product. The data retained in this standard can be used as an effective source for future tracking.

  • Read More BiOptic - Surveillance Pooling Test models

    BiOptic - Surveillance Pooling Test models

    2021-01-22

    As the weather turned cooler in parts of the northern hemisphere, the COVID-19 pandemic is getting serious again in lots of countries. From the beginning of this pandemic, every health organization around the world has put a lot of efforts on finding the right strategy to stop it. Somehow, it seems that there is no effective way.